Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
Contained in the library are leading modulators, each labelled with 38 ADME-Tox and 32 physicochemical and drug-likeness qualities. In addition, each compound is illustrated with its optimal docking poses, affinity scores, and activity scores, giving a complete picture.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
By deploying molecular simulations, our approach comprehensively covers a broad array of proteins, tracking their flexibility and dynamics individually and within complexes. Ensemble virtual screening is utilised to take into account conformational dynamics, identifying pivotal binding sites located within functional regions and at allosteric locations. This thorough exploration ensures that every conceivable mechanism of action is considered, aiming to identify new therapeutic targets and advance lead compounds throughout a vast spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
P62263
UPID:
RS14_HUMAN
Alternative names:
40S ribosomal protein S14
Alternative UPACC:
P62263; B2R5G5; D3DQG5; P06366; Q5BJI0
Background:
The Small ribosomal subunit protein uS11, also known as 40S ribosomal protein S14, plays a pivotal role in protein synthesis. As a component of the small ribosomal subunit, it is integral to the ribosome's function in translating mRNA into polypeptide chains. This process involves intricate mechanisms including RNA folding, modifications, and cleavage, facilitated by the SSU processome in the nucleolus.
Therapeutic significance:
Understanding the role of Small ribosomal subunit protein uS11 could open doors to potential therapeutic strategies. Its critical function in protein synthesis underscores its potential as a target for interventions in diseases where protein synthesis plays a part.